Glenmark Pharmaceuticals reports consolidated net profit of Rs 347.96 crore in the December 2024 quarter
Sales rise 34.21% to Rs 3301.90 crore
Net profit of Glenmark Pharmaceuticals reported to Rs 347.96 crore in the quarter ended December 2024 as against net loss of Rs 351.37 crore during the previous quarter ended December 2023. Sales rose 34.21% to Rs 3301.90 crore in the quarter ended December 2024 as against Rs 2460.29 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var.Sales3301.902460.29 34 OPM %18.18-8.48 -PBDT579.06-297.58 LP PBT456.33-444.66 LP NP347.96-351.37 LPPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content